In January 2024, researchers in the U.K. published a study in the journal Nature Medicine proposing that several people who received cadaveric growth hormone between 1959 and 1989 as a treatment ...
LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces the launch by its Rex MD men’s health brand of TestoRx, a new direct-to-consumer men’s hormone therapy ...